Alembic Pharmaceuticals Limited (BOM:533573)
India
· Delayed Price · Currency is INR 899.90
-2.30 (-0.25%)
At close: Dec 5, 2025
Alembic Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 176,867 | 182,755 | 193,575 | 97,564 | 145,771 | 189,674 | Upgrade
|
| Market Cap Growth | -12.18% | -5.59% | 98.41% | -33.07% | -23.15% | 88.33% | Upgrade
|
| Enterprise Value | 190,292 | 192,124 | 200,785 | 104,548 | 151,109 | 193,139 | Upgrade
|
| Last Close Price | 899.90 | 919.07 | 960.73 | 479.74 | 706.21 | 906.13 | Upgrade
|
| PE Ratio | 27.88 | 31.33 | 31.43 | 28.53 | 27.98 | 16.54 | Upgrade
|
| PS Ratio | 2.50 | 2.74 | 3.11 | 1.73 | 2.75 | 3.52 | Upgrade
|
| PB Ratio | 3.33 | 3.52 | 4.02 | 2.23 | 2.78 | 3.74 | Upgrade
|
| P/TBV Ratio | 3.47 | 3.52 | 4.02 | 2.23 | 2.87 | 4.00 | Upgrade
|
| P/FCF Ratio | - | - | 40.69 | 34.78 | 115.04 | 23.60 | Upgrade
|
| P/OCF Ratio | 29.88 | 207.75 | 24.10 | 13.48 | 26.39 | 12.96 | Upgrade
|
| EV/Sales Ratio | 2.69 | 2.88 | 3.22 | 1.85 | 2.85 | 3.58 | Upgrade
|
| EV/EBITDA Ratio | 16.84 | 19.42 | 21.97 | 15.02 | 17.60 | 13.17 | Upgrade
|
| EV/EBIT Ratio | 22.62 | 26.33 | 30.39 | 23.88 | 25.72 | 14.89 | Upgrade
|
| EV/FCF Ratio | -1196.80 | - | 42.21 | 37.27 | 119.26 | 24.03 | Upgrade
|
| Debt / Equity Ratio | 0.28 | 0.24 | 0.11 | 0.17 | 0.14 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 1.32 | 1.25 | 0.55 | 1.01 | 0.82 | 0.39 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.08 | 2.57 | 5.66 | 0.73 | Upgrade
|
| Asset Turnover | 0.91 | 0.94 | 0.99 | 0.85 | 0.77 | 0.85 | Upgrade
|
| Inventory Turnover | 0.87 | 0.96 | 1.15 | 1.15 | 0.97 | 1.00 | Upgrade
|
| Quick Ratio | 0.54 | 0.62 | 0.82 | 0.74 | 0.52 | 0.51 | Upgrade
|
| Current Ratio | 1.59 | 1.70 | 2.12 | 1.78 | 1.67 | 2.07 | Upgrade
|
| Return on Equity (ROE) | 12.38% | 11.63% | 13.40% | 7.12% | 10.11% | 27.77% | Upgrade
|
| Return on Assets (ROA) | 6.72% | 6.42% | 6.54% | 4.11% | 5.31% | 12.77% | Upgrade
|
| Return on Capital (ROIC) | 8.23% | 7.75% | 7.92% | 4.95% | 6.33% | 15.19% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.80% | 13.60% | 13.20% | 9.60% | 10.90% | 23.90% | Upgrade
|
| Earnings Yield | 3.59% | 3.19% | 3.18% | 3.50% | 3.57% | 6.04% | Upgrade
|
| FCF Yield | -0.09% | -2.60% | 2.46% | 2.88% | 0.87% | 4.24% | Upgrade
|
| Dividend Yield | 1.22% | 1.20% | 1.15% | 1.67% | 1.42% | 1.54% | Upgrade
|
| Payout Ratio | 34.08% | 37.06% | 25.54% | 57.48% | 52.83% | - | Upgrade
|
| Buyback Yield / Dilution | 0.11% | - | - | - | -1.46% | -2.77% | Upgrade
|
| Total Shareholder Return | 1.33% | 1.20% | 1.15% | 1.67% | -0.04% | -1.23% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.